[Federal Register Volume 77, Number 191 (Tuesday, October 2, 2012)]
[Notices]
[Pages 60145-60146]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-24194]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Apertus Pharmaceuticals, LLC

    By Notice dated June 4, 2012, and published in the Federal Register 
on June 12, 2012, 77 FR 35058, Apertus Pharmaceuticals, LLC., 331 
Consort Drive, St Louis, Missouri 63011, made application to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Alfentanil (9737)..........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards for distribution to 
their customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Apertus Pharmaceuticals, LLC., to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time.
    DEA has investigated Apertus Pharmaceuticals, LLC., to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 
1301.33,

[[Page 60146]]

the above named company is granted registration as a bulk manufacturer 
of the basic classes of controlled substances listed.

    Dated: September 25, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-24194 Filed 10-1-12; 8:45 am]
BILLING CODE 4410-09-P